Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lirui Wang

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 2, 2018
Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosisJian-Bin Qiao, Qian-Qian Fan, Lei Xing, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 28, 2021
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver DiseaseMinyi Qian, Jun Liu, Danyang Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2019
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesityLirui Wang, Magdalena Mazagova, Chuyue Pan, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in micePhillipp Hartmann, Katrin Hochrath, Angela Horvath, et al.
Nature Communications|December 14, 2017
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
Nature Communications|October 18, 2017
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
The Journal of Clinical Investigation|May 23, 2017
Intestinal fungi contribute to development of alcoholic liver diseaseAn-Ming Yang, Tatsuo Inamine, Katrin Hochrath, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 25, 2021
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in MiceRongrong Zhou, Cristina Llorente, Jinling Cao, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 2, 2018
Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosisJian-Bin Qiao, Qian-Qian Fan, Lei Xing, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 28, 2021
Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver DiseaseMinyi Qian, Jun Liu, Danyang Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2019
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesityLirui Wang, Magdalena Mazagova, Chuyue Pan, et al.
Hepatology (Baltimore, Md.)|November 22, 2017
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in micePhillipp Hartmann, Katrin Hochrath, Angela Horvath, et al.
Nature Communications|December 14, 2017
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
Nature Communications|October 18, 2017
Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
The Journal of Clinical Investigation|May 23, 2017
Intestinal fungi contribute to development of alcoholic liver diseaseAn-Ming Yang, Tatsuo Inamine, Katrin Hochrath, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 25, 2021
Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in MiceRongrong Zhou, Cristina Llorente, Jinling Cao, et al.
Pageof 9